Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 17 of 17 for “"virus purification"”.
-
Virus purification, detection and removal
… and an increasing need to improve the current virus purification technologies, especially as more and more vaccines are produced from cell-culture derived virus particles. Downstream purification strategies can be expensive and account for 70% of the overall manufacturing costs. The economic …
-
Virus Purification Framework And Enhancement In Aqueous Two-Phase System
… significant success in yielding high titers of viruses and virus-like particles. The progress in the upstream stage has now shifted the bottleneck to the downstream processing (DSP). Overlooked for decades, the DSP responsible for viral product purification from the cell culture contaminants …
-
Maize dwarf mosaic virus: purification, some physical properties, and yield of virus from several corn hybrids
… understand the nature of maize dwarf mosaic virus (MDMV) and its interaction with susceptible and resistant corn hybrids, the purification of MDMV and its physical properties were re-evaluated and a rapid assay procedure was developed. The virus was purified by chloroform clarification and …
-
Application of Paper Electrochromatography to Isolation of Tobacco Mosaic Virus
Importance of the problem The complete study of a virus disease often reaches a stalemate because of failure to isolate the virus itself in a purified form. Methods in current use, such as ultracentrifugation, precipitation, fractionation, and spectroscopic analysis, have in some cases proved …
-
Advancing membrane chromatography processes for the purification of therapeutic viruses
Viruses have emerged as a new class of biotherapeutics used as vectors in gene and cell therapies, vaccines, and as oncolytic agents in novel cancer immunotherapies. While these new and potentially curative new therapies bring great promise for patients, the large-scale purification of viruses is …
-
Enhanced pest management of the Douglas-fir tussock moth, Orgyia pseudotsugata (Lepidoptera: Lymantriidae)
The incidence of baculovirus disease in susceptible insect hosts may be used to estimate future host population sizes and estimate the relative defoliation of these populations for economically important insects. We developed an Enzyme-linked immunosorbent assay (ELISA) that was specific to two …
-
The structural characterization of mammalian reovirus RNA-dependent RNA polymerase, capsid morphology, and capsid dynamics
Viruses maintain high structural stability during the extracellular portions of their replicative cycles, yet are significantly dynamic during other stages in their life cycle. Despite the extensive studies that have characterized the various structural proteins found within the capsid layers of …
-
The production, harvest and adsorptive recovery of an infectious herpes simplex virus vaccine
… there is not a reliable vaccine against herpes virus. Viral protein vaccines as yet have proved unsuccessful to meet the challenge of raising an appropriate immune response. Cantab Pharmaceuticals has produced a virus vaccine that can undergo one round of replication in the recipient in order to …
-
CONTINUOUS, PLATFORM PURIFICATION OF VIRAL PRODUCTS USING AQUEOUS TWO-PHASE EXTRACTION
… Most cell and gene therapies are delivered using virus-based delivery vectors, which are incredibly expensive to manufacture. Liquid chromatography is the favored method of viral vector purification since it is easily scalable and can be functionalized to purify by biospecificity, charge, …
-
MEASURING THE PHYSICOCHEMICAL PROPERTIES OF VIRAL VECTORS TO ENHANCE GENE THERAPY PRODUCTION
… by manufacturing challenges inclusive of low virus recovery, and the presence of AAV without the gene of interest (empty capsids). To solve these problems, we characterized the charge and hydrophobicity of AAV, and surrogate viruses using chemical force microscopy (CFM). CFM uses a modified …
-
PURIFICATION AND EFFECTIVENESS OF VACCINES AND ANTIVIRAL COMPOUNDS
… and glycine reduce the infectivity of a model virus, porcine parvovirus (PPV), by 4 LRV (99.99%), likely by disruption of capsid assembly. These osmolytes have the potential to be used as drugs, since they showed antiviral activity after 20 h. We have also focused on improving current vaccine …
-
Feline leukaemia virus-specific proteins
… with the polypeptides of feline leukaemia virus (FeLV), both the structural polypeptides of the virus particle and putative non-structural proteins which appear in FeLV-infected and transformed cells. In the first part of the work (Chapter Two) it was established that virus purification and …
-
Continuous viral vaccine manufacturing and viral detection strategies
Viruses are responsible for many human diseases that lead to suffering and death. Acquired immunodeficiency syndrome (AIDS), influenza, and coronavirus disease 2019 (COVID-19) have claimed the lives of millions of people. Two methods have been created to reduce the suffering caused by these …
-
Processing and Control of Human Norovirus and Surrogates in Engineered Water Reuse Systems
Human noroviruses (hNoVs) are the number one cause of acute gastroenteritis outbreaks globally across all age groups. However, our knowledge of the environmental persistence of hNoVs has been hampered by the lack of cell culture model suitable for environmental studies. As a result, researchers …
-
HOST RESPONSES TO RECOMBINANT BACULOVIRAL VECTORS IN ANIMAL MODELS
Recombinant insect baculoviruses (rBV) have been emerging as promising gene delivery vectors. Though mammalian host responses to baculoviral transduction is not yet completely known, there have been reports of rBV eliciting immune responses and getting inactivated by serum complement system, thus …
-
Production of Preclinical Grade Recombinant Newcastle disease viruses to Enhance Tumor Specific Immune Responses in Syngeneic Mouse Models of Cancer
Oncolytic virus (OV) therapy is an experimental form of biological therapy has shown increasing potential over the last decade, culminating with the first FDA approval of an OV therapy, the Herpes simplex virus Talimogene laherparepvec (T-VEC), in 2015. Newcastle disease virus (NDV), a promising OV …